Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SPF and UVA Protection Efficacy of BAY987517
NCT02815202Completed
- Sponsor
- Bayer
- Start
- Jun 2016
- Primary completion
- Jun 2016
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of BAY987517 in sunburn, sponsored by Bayer. Primary endpoints: Minimal Erythema Dose at 15 months and Minimal Persistent Pigment Darkening Dose at 15 months. Started Jun 2016; status: completed.
02
Drugs
BAY987517
03
Conditions
sunburn
Beyond the preview
Go deeper on NCT02815202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02815202.